Annual Shareholders Equity
$391.27 M
-$7.88 M-1.97%
31 December 2023
Summary:
Castle Biosciences annual stockholders equity is currently $391.27 million, with the most recent change of -$7.88 million (-1.97%) on 31 December 2023. During the last 3 years, it has fallen by -$24.42 million (-5.88%). CSTL annual shareholders equity is now -5.88% below its all-time high of $415.69 million, reached on 31 December 2020.CSTL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$441.06 M
+$17.16 M+4.05%
30 September 2024
Summary:
Castle Biosciences quarterly stockholders equity is currently $441.06 million, with the most recent change of +$17.16 million (+4.05%) on 30 September 2024. Over the past year, it has increased by +$55.27 million (+14.33%). CSTL quarterly shareholders equity is now at all-time high.CSTL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.0% | +14.3% |
| 3 y3 years | -5.9% | +7.1% |
| 5 y5 years | +3985.5% | +435.7% |
CSTL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | at low | at high | +16.4% |
| 5 y | 5 years | -5.9% | +3985.5% | at high | +435.7% |
| alltime | all time | -5.9% | +2841.7% | at high | +4479.9% |
Castle Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $441.06 M(+4.0%) |
| June 2024 | - | $423.89 M(+5.3%) |
| Mar 2024 | - | $402.46 M(+2.9%) |
| Dec 2023 | $391.27 M(-2.0%) | $391.27 M(+1.4%) |
| Sept 2023 | - | $385.78 M(+1.9%) |
| June 2023 | - | $378.77 M(-1.7%) |
| Mar 2023 | - | $385.15 M(-3.5%) |
| Dec 2022 | $399.15 M(-3.1%) | $399.15 M(-3.0%) |
| Sept 2022 | - | $411.43 M(-2.4%) |
| June 2022 | - | $421.66 M(+6.1%) |
| Mar 2022 | - | $397.34 M(-3.5%) |
| Dec 2021 | $411.74 M | $411.74 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $411.71 M(-1.0%) |
| June 2021 | - | $415.92 M(-0.6%) |
| Mar 2021 | - | $418.59 M(+0.7%) |
| Dec 2020 | $415.69 M(+388.4%) | $415.69 M(+149.6%) |
| Sept 2020 | - | $166.56 M(+5.7%) |
| June 2020 | - | $157.62 M(+79.3%) |
| Mar 2020 | - | $87.93 M(+3.3%) |
| Dec 2019 | $85.11 M(-945.2%) | $85.11 M(+3.4%) |
| Sept 2019 | - | $82.34 M(-2391.1%) |
| June 2019 | - | -$3.59 M(-279.6%) |
| Mar 2019 | - | $2.00 M(-119.9%) |
| Dec 2018 | -$10.07 M(-29.4%) | -$10.07 M |
| Dec 2017 | -$14.27 M | - |
FAQ
- What is Castle Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Castle Biosciences?
- What is Castle Biosciences annual shareholders equity year-on-year change?
- What is Castle Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Castle Biosciences?
- What is Castle Biosciences quarterly shareholders equity year-on-year change?
What is Castle Biosciences annual stockholders equity?
The current annual shareholders equity of CSTL is $391.27 M
What is the all time high annual shareholders equity for Castle Biosciences?
Castle Biosciences all-time high annual stockholders equity is $415.69 M
What is Castle Biosciences annual shareholders equity year-on-year change?
Over the past year, CSTL annual stockholders equity has changed by -$7.88 M (-1.97%)
What is Castle Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of CSTL is $441.06 M
What is the all time high quarterly shareholders equity for Castle Biosciences?
Castle Biosciences all-time high quarterly stockholders equity is $441.06 M
What is Castle Biosciences quarterly shareholders equity year-on-year change?
Over the past year, CSTL quarterly stockholders equity has changed by +$55.27 M (+14.33%)